COMPOSITION FOR ENHANCING SOLUBILITY OF ACTIVE SUBSTANCES, METHOD FOR PREPARATION OF THE COMPOSITION, AND USE OF THE COMPOSITION - Patent application
The use of ground shell materials to sorb active substances addresses the limitations of existing solubility enhancement methods, providing a cost-effective, environmentally friendly, and high-solubility solution for active substances, applicable in diverse fields.
Patent Information
- Application Number
- JP2024523628
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2021-10-21
- Filing Date
- 2022-10-19
- Publication Date
- 2024-11-08
AI Technical Summary
Existing methods for increasing the solubility of active substances are costly, environmentally unfriendly, and require individual formulations for each active ingredient, while current nanocrystals and porous materials have limitations such as low solubility enhancement and potential health risks.
A composition using ground shell material, such as eggshells or nutshells, to sorb active substances, enhancing solubility up to five times by adsorption or absorption, allowing for biodegradability and cost-effective production from renewable materials.
The composition achieves high solubility enhancement and bioavailability of active substances, enabling sustainable and efficient delivery across various applications, including pharmaceutical, medical, and agricultural uses.
Smart Images

Figure 2024541210000001_ABST
Abstract
Description
[Technical field]
[0001] The present invention relates to a composition for enhancing the solubility of an active substance, a method for preparing the composition, and uses of the composition. [Background technology]
[0002] An active substance can only be absorbed by the body if it is available in dissolved form at the absorption site. This is currently a problem in many cases: there are many substances that cannot be absorbed by the body or can be absorbed only poorly due to their low solubility. This affects up to 90% of all newly synthesized active ingredients in pharmacies. Therefore, strategies must be found to make such active ingredients easily soluble.
[0003] Currently, various strategies exist to enhance solubility, such as so-called nanocrystals, solid solutions, mixed crystals, and porous materials (such as porous silica).
[0004] Nanocrystals are currently the most commonly used formulation strategy in terms of the number of products on the market. The disadvantage of nanocrystals is that their solubility is only about 2-3 times higher.
[0005] Mixed crystals and solid solutions achieve good solubility enhancement. However, they are not a universal strategy and individual formulations have to be developed for each individual active ingredient, which is time-consuming and costly. The additives used for this purpose are often expensive and not very environmentally friendly. This applies both to production and to biodegradability. Therefore, there are only a few products on the market.
[0006] Porous materials, by comparison, should be considered a relatively "young" technology in terms of enhancing solubility. The currently recognized principle of enhancing solubility is to incorporate the active ingredient in amorphous form into nanoscale pores (mesopores). The enhancement of solubility by this method is very good (usually 3-10 times). The disadvantage of this method is the use of silicate particles, which cannot be degraded in the body (and naturally) and, depending on their origin, may contain high amounts of aluminum (suspected of promoting the development of Alzheimer's disease). The production of porous silicate particles is also expensive and not environmentally friendly. The production of tablets of porous materials is only possible by adding various excipients, so the amount of silicate particles added is less than 10%, and therefore the total amount of active ingredient (loaded into the silicate particles) is correspondingly small.
[0007] MM Than (Mahidol University Journal of Pharmaceutical Sciences, 2012, 39(3-4), p.32-38) describes the use of eggshell powder as an excipient in immediate and sustained release acetaminophen tablets. In this case of acetaminophen, the active substance is only physically mixed with the eggshell powder and is not sorbed onto it. Summary of the Invention [Problem to be solved by the invention]
[0008] The technical objective underlying the present invention is to provide particles, methods for producing particles and uses of particles, which are made of materials that are harmless (both in the body and in the environment) and preferably biodegradable, can be produced from renewable raw materials in a cost-effective and environmentally friendly manner, and furthermore ensure a large capacity in the final formulation for loading of active ingredients. [Means for solving the problem]
[0009] This object is solved by the independent claims. Preferred embodiments are defined in the dependent claims.
[0010] In accordance with the present invention, there is provided a composition for increasing the solubility of an active agent, the composition comprising a milled shell material on or within which the active agent is sorbed.
[0011] As used herein, "sorption" is a general term for processes that lead to the accumulation of a substance in a phase or at the interface between two phases. More precisely, enrichment within a phase is called "absorption" and enrichment at an interface is called "adsorption". Thus, the term "sorbed" as used in accordance with the present invention encompasses absorption, adsorption, and a mixture of both.
[0012] In one embodiment, the composition according to the invention is obtained by dissolving the active substance in a solvent other than the one in which the solubility of the active substance is to be increased, to obtain a solution, mixing the solution with the ground shell material, and optionally removing at least a part of the solvent in which the active substance is dissolved. The detailed process steps are described in more detail below when describing the method according to the invention, so please refer to that. It should be noted that since it is not clear whether the process of sorption of the active substance on the ground shell material is adsorption, absorption or a mixture of both, a reasonable way to describe the composition is the description of its preparation method.
[0013] Furthermore, it may be the case that an active substance is poorly or not at all soluble in one solvent, but readily soluble in another. When carrying out the process for preparing the composition according to the invention, a solvent is naturally selected which dissolves the active substance, but which is not one which should enhance the solubility of the active substance.
[0014] The term "active substance" refers to any substance that has a desired effect. Specifically, an active substance is a substance that has a specific effect or induces a specific reaction in vivo. In one embodiment, the active substance is an active pharmaceutical ingredient. Usually, for substances with low solubility, their solubility must be increased, especially in the physiological environment of the human or animal body. The active substance used in the composition according to the present invention may be slightly soluble, slightly soluble, very slightly soluble, or almost insoluble, with "slightly soluble" meaning that 30 to 100 times the volume of the solvent is required to dissolve 1 mass unit of the substance at 15°C to 25°C, and similarly "slightly soluble" meaning that 100 to 1000 times the volume of the solvent is required, "very slightly soluble" meaning that 1000 to 10000 times the volume of the solvent is required, and "almost insoluble" meaning that more than 10000 times the volume of the solvent is required.
[0015] For the purposes of the present invention, shell material refers to the outer shells or shells of seeds, fruits or nuts, as well as the carapaces of mollusks. In one embodiment, the crushed shell material may be selected from crushed eggshells and / or crushed nut shells. The term "and / or" here means that a mixture of crushed eggshells and crushed nut shells may also be used.
[0016] The composition according to the invention may contain crushed eggshell. Any egg may be used to obtain the eggshell, but hen's eggs are preferred, as they are readily available and are used as food, making them acceptable for pharmaceutical use. Shell material may be obtained from nuts, particularly walnuts, which are also readily available. The term "crushed" here indicates that the shell material used in the composition according to the invention is smaller in size than the natural shell material. Crushed eggshell is commercially available as a nutritional supplement for dogs and cats.
[0017] In one embodiment, the ground shell material is present as ground, powdered, micronized or ultrafine material. The shell material is ground (by a grinding machine), crushed and pulverized during grinding. Powder here refers to a (nearly) finely ground, crushed or ground material. Micronization is a significant reduction in the average particle size, from a typical particle size of 100 μm to 1000 μm to a range of 2 μm to 200 μm. In ultrafine material, the ground shell material is present in nanoscale. These are conventional techniques for grinding materials. The methods and materials for carrying them out are known to the person skilled in the art. Grinding to nanoscale may be carried out in the presence of a liquid.
[0018] In one embodiment, the ground shell material is present as a coarse, medium, fine, or fine powder. The fineness of the powder may be characterized by assigning one or two sieve numbers and determining the percentage m / m of material passing through each sieve. The European Pharmacopoeia sieve table lists 18 standard sieves, using the clear square mesh size (μm) as the sieve number, which are: 11200, 8000, 5600, 4000, 2800, 2000, 1400, 1000, 710, 500, 355, 250, 180, 125, 90, 63, 45, 38. When two sieves are used, a sieve size (A) is determined through which 95% or more of the sample passes, and a second sieve size (B) through which 40% or less passes. Based on this method, the European Pharmacopoeia defines four particle classes: Particle class Sieve (A) Sieve (B) Coarse particles 1400 355 Medium particles 1400 355 Fine particles 180 125 Fine particles 125 90
[0019] In one embodiment, the crushed shell material is charged with between 0.1% and 100% of the maximum charge capacity of crushed shell material having active substances.
[0020] In another embodiment, the composition is in the form of a suspension, cream, gel, ointment, paste, capsule, granule, pellet, tablet, drop, spray, suppository, lozenge, patch, pen. These are typical formulations in the pharmaceutical field. Those skilled in the art know the methods and materials to achieve these formulations, i.e. to provide the composition according to the invention in the form of these formulations.
[0021] In one embodiment, the composition according to the invention further comprises a compound selected from the group consisting of C3-C10 trihydroxy compounds (e.g., glycerol) and / or an acid (e.g., citric acid). Surprisingly, it has been found that the addition of these further compounds increases the passive penetration (e.g., transdermal penetration) of the active agent.
[0022] The present invention shows that a composition according to the invention can be obtained by simply adding ground shell material (ground, powdered, micronized or micronized), such as ground eggshell and / or ground nut shell, to an active ingredient solution. After removal of the solvent (e.g. after evaporation), the active ingredient accumulates in or on the shell particles, increasing the solubility of the active ingredient by up to 5 times. Higher solubility increases the penetration of the active ingredient. This technology allows low solubility active ingredients to be easily bioavailable. Fields of application are oral application, topical application. For application in or on human, animal or other surfaces (e.g. for application of low solubility fertilizers, pesticides, surface disinfectants, etc.).
[0023] Eggshells are approved as foodstuffs and therefore harmless in their application. Eggshells can be obtained from renewable raw materials and are particularly easily and cheaply available as waste products. Any type of active substance can be loaded onto and / or into the shell material. It is therefore a universal method. The shell material loaded (or not) with active substance can be applied directly as a powder or can be incorporated into liquid or semi-solid formulations, filled into capsules or simply compressed into tablets. Research has shown that tablets obtained in this way meet the regulatory requirements of the European Pharmacopoeia. Eggshell formulations can therefore be used in a wide range of fields (pharmaceuticals, medical, food, cosmetics, textile industry, paints and coatings, agriculture, etc.) as a novel, cost-effective and particularly environmentally friendly method for improving the effectiveness of low-solubility substances. The principle is simple yet smart: it is easy to manufacture, versatile and therefore highly practical.
[0024] The present invention further relates to a method for preparing a composition for increasing the solubility of an active substance, in particular the composition described above according to the present invention, which comprises a ground shell material on or in which the active substance is sorbed, said composition being obtained by dissolving the active substance in a solvent other than the solvent in which the solubility of the active substance is to be increased, mixing said solution with the ground shell material, and optionally removing at least a portion of the solvent in which the active substance is dissolved, to obtain a solution.
[0025] The desired active substance is dissolved in a suitable solvent and the solution is applied to the ground shell material. As pointed out above, it is possible that the active substance is soluble in one solvent but not in another. When preparing the composition, a solvent in which the active substance is soluble is selected, since otherwise sorption is not possible. Such a suitable solvent may also be acceptable for pharmaceutical use. Typical suitable solvents are ethanol or oil. The solvent is allowed to evaporate. To facilitate this process, stirring and / or heating and / or the use of a solvent extraction system may be used. After the optional solvent removal is substantially complete, the charged shell material is present as a powder, which may be used as is or may be further processed into other formulations (suspensions, creams, gels, ointments, pastes, capsules, granules, pellets, tablets, drops, sprays, suppositories, lozenges, patches, pens, etc.).
[0026] By sorbing the active substance in or on the eggshell, the solubility of the active ingredient is increased, which results in improved passive diffusion (bioavailability).The active substance can be released in a sustained manner, allowing for long-term application.Surprisingly, it has been found that the addition of acid and glycerol to the composition enhances passive permeation.
[0027] In one embodiment, the step of removing at least a portion of the solvent is carried out by applying heat and / or reduced pressure. In general, it is appropriate but not necessary to completely remove the solvent. Solvent, especially small amounts of solvent, may remain present as long as there is no adverse effect on the subsequent use of the composition according to the invention.
[0028] In one embodiment, the mixture of solvent and ground shell material is agitated. This agitation may be performed before and / or during solvent removal. Agitation refers to the circular motion of the liquid components to mix them uniformly.
[0029] As pointed out above, the compositions according to the invention may be used to prepare suspensions, creams, gels, ointments, pastes, capsules, granules, pellets, tablets, drops, sprays, suppositories, lozenges, patches, pens.
[0030] Depending on the type of active substance, the compositions according to the invention may be used for pharmaceutical, medical, food, cosmetics, textile industry, paints and coatings, agriculture (eg fertilizers).
[0031] The present invention will be further illustrated with reference to the following examples and drawings, which are intended to be illustrative of the present invention and should not be construed as limiting the present invention thereto. [Brief description of the drawings]
[0032] [Figure 1] Fluorescence microscopy images of skin sections of untreated skin (A), skin treated with a bulk material (B), skin treated with a physical mixture (C), and skin treated with a composition according to the invention (D) are shown at 200x magnification, with the size scale corresponding to 50 μm. [Diagram 2] Figure 1 shows the effect of additives on curcumin penetration. The addition of glycerol, and acid plus glycerol, significantly increased the penetration of curcumin into the skin (one-way ANOVA with Bonferroni-Holm corrected post-hoc analysis). [Diagram 3] Figure 1 shows the X-ray diffraction patterns of pure curcumin raw powder, unloaded nut shells, nut shells loaded with curcumin, and physical mixtures. A: Loaded with 1% curcumin extract. B: Loaded with 10% curcumin extract. C: Loaded with 20% curcumin extract. [Figure 4] The release of curcumin in water is shown. **-p<0.01 (Welch's test, n=3). DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0033] Example 1 Solubility
[0034] Curcumin is a low solubility substance and in this experiment it served as a surrogate for a very poorly soluble active ingredient. The goal was to show that the solubility of a low solubility substance can be increased by incorporating it into eggshell. First, curcumin was incorporated into eggshell powder. Two different methods were used for this purpose: Method 1 - Curcumin was dissolved in ethanol and the solution was placed on top of the eggshell. The ethanol was allowed to evaporate without stirring (HP). Method 2 - Curcumin was dissolved in ethanol and the solution was placed on top of the eggshell. The ethanol was allowed to evaporate with stirring (R). For comparison, curcumin was mixed with ground eggshell (physical mixture = PM) and added to water as a pure substance (bulk). The amount of dissolved curcumin was measured for all samples. The results showed that when curcumin was incorporated into eggshell, the water turned a deep yellow color. That is, curcumin was effectively dissolved in the aqueous phase. No discoloration of the aqueous phase occurred with the physical mixture and the pure substance. Thus, no curcumin was dissolved there. The amount of dissolved curcumin was measured at various time points by UV-Vis measurements. In the case of method 1, the solubility of curcumin was about 100 times higher than in the control solution of pure curcumin. In the case of method 2, the solubility was about 50 times higher.
[0035] The charged eggshell contained 10% (w / w) curcumin, i.e. 90% eggshell and 10% curcumin. The physical mixture contained approximately the same amount.
[0036] Example 2 Biological efficacy
[0037] The goal was to show that passive penetration of low solubility active ingredients, i.e., loading into eggshells, can improve their bioavailability. Skin availability was tested in an in vitro pig ear model. Curcumin-loaded eggshells (method 1 in Example 1) were mixed with water in a 1:1 ratio and applied to fresh, intact pig skin. After 4 hours of penetration, the amount of active ingredient that penetrated was analyzed. Pure curcumin powder was dispersed in water and its physical mixture served as the control. Curcumin loaded into crushed eggshells was able to effectively penetrate the skin and transdermal penetration was observed. Pure curcumin powder and the physical mixture penetrated the upper layers of the skin to a small extent, but no transdermal penetration was observed (Figures 1A-1D).
[0038] Example 3 Optimization of biological effectiveness with additives
[0039] Surprisingly, the addition of glycerol and acid (citric acid) to the curcumin-loaded eggshells was found to increase the bioavailability of curcumin again by approximately 25% (Figure 2).
[0040] Example 4 Use for oral application
[0041] The coarse ground eggshell was manually compressed into tablets, demonstrating that pharmaceutical quality tablets can be produced from coarse ground eggshell by direct compression without the addition of further excipients.
[0042] Example 5 Composition containing curcumin and nut shells
[0043] An ethanolic solution of curcumin containing 0.5% (w / v) of curcumin extract was added to the nut shells. The ethanol was evaporated and the resulting nut shells contained either 1%, 10%, 20% or 40% of curcumin extract (w / w). The crystallinity of the curcumin loaded into the nut shells was measured by X-ray diffraction and the resulting diffraction patterns were compared with physical mixtures containing nut shells and raw bulk powder of curcumin extract. Raw curcumin extract powder and unloaded nut shells served as controls (Figure 3). The raw bulk curcumin material showed typical reflections of crystalline curcumin. These reflections were also visible in the physical mixture but disappeared when curcumin was loaded into the nut shells. This indicates that curcumin was loaded into the nut shells in an amorphous state (Figure 3).
[0044] The amount of curcumin released after adding water was analyzed by measuring the fluorescence intensity of the supernatant after adding water to the curcumin-loaded nut shells. Raw powder extract of curcumin served as the control. The curcumin released from the nut shells was 577% compared to the control (Figure 4).
Claims
1. A composition that enhances the solubility of an active agent, the composition comprising a ground shell material, the active agent being sorbed onto or within the ground shell material.
2. 2. The composition according to claim 1, wherein the composition is obtained by dissolving the active substance in a solvent other than the solvent in which the solubility of the active substance is to be increased to obtain a solution, mixing the solution with the ground shell material, and optionally removing at least a portion of the solvent in which the active substance is dissolved.
3. The composition of claim 1 or 2, wherein the active agent is an active pharmaceutical ingredient.
4. The composition according to any one of claims 1 to 3, wherein the ground shell material is ground egg shells and / or ground nut shells.
5. A composition according to any one of claims 1 to 4, wherein the crushed eggshells are derived from hen's eggs and / or the crushed nut shells are derived from nuts, in particular walnuts.
6. The composition of any one of claims 1 to 5, wherein the ground shell material is present as ground, powdered, micronized, or micronized material.
7. The composition of any one of claims 1 to 6, wherein the ground shell material is present as a coarse, medium, fine, or fine powder.
8. 8. The composition of any one of claims 1 to 7, wherein the crushed shell material is loaded with 0.1% to 100% of the maximum loading capacity of the crushed eggshell with the active substance.
9. The composition according to any one of claims 1 to 8, wherein the composition is in the form of a suspension, cream, gel, ointment, paste, capsule, granule, pellet, tablet, drop, spray, suppository, lozenge, patch, pen.
10. The composition according to any one of claims 1 to 9, further comprising a compound selected from the group consisting of C3-C10 trihydroxy compounds and / or an acid.
11. A method for preparing a composition for increasing the solubility of an active substance, the composition comprising a milled shell material on or in which the active substance is sorbed, the composition being obtained by the steps of dissolving the active substance in a solvent other than the solvent in which the solubility of the active substance is to be increased to obtain a solution, and mixing the solution with the milled shell material.
12. 12. The method of claim 11, wherein at least a portion of the solvent in which the active substance is dissolved is removed, said removing at least a portion of the solvent being preferably performed by application of heat and / or reduced pressure.
13. The method according to any one of claims 11 to 12, wherein the mixture of solvent and ground shell material is stirred.
14. Use of a composition according to any one of claims 1 to 10 in the form of a suspension, cream, gel, ointment, paste, capsule, granule, pellet, tablet, drop, spray, suppository, lozenge, patch, pen.
15. Use of the composition according to any one of claims 1 to 10 for pharmaceutical, medical, food, cosmetics, textile industry, paints and coatings, agriculture.
